Cervical Cancer as a Global Concern – Contributions of the Dual Epidemics of HPV and HIV

JAMA
October 22/29, 2019, Vol 322, No. 16, Pages 1527-1620
http://jama.jamanetwork.com/issue.aspx

 

Editorial
Cervical Cancer as a Global Concern – Contributions of the Dual Epidemics of HPV and HIV
Carla J. Chibwesha, MD, MSc; Jeffrey S. A. Stringer, MD
JAMA. 2019;322(16):1558-1560. doi:10.1001/jama.2019.16176
of the uterine cervix is among the most preventable human malignancies,1,2 yet it remains a leading cause of death among women worldwide, accounting for more than 300 000 deaths annually.3 Well on its way to elimination in the global north, cervical cancer mostly affects women living in low- or middle-income countries (LMICs), where limited access to vaccination, screening, and therapy have made it overwhelmingly a disease of women who are poor and lack access to health care. Nowhere is this more evident than in sub-Saharan Africa, where HIV is endemic and where cervical cancer has surpassed breast cancer as the most common and deadly cancer in women.3